- Trials with a EudraCT protocol (104)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
104 result(s) found for: Hip arthroplasty.
Displaying page 1 of 6.
EudraCT Number: 2016-000926-21 | Sponsor Protocol Number: AMSC-BDT-002 | Start Date*: 2016-10-06 | |||||||||||
Sponsor Name:Fakultní nemocnice Hradec Králové | |||||||||||||
Full Title: Innovation of method cryopreservation for clinical use autologous multipotent mesenchymal stem cells (MSCs) for treatment of extensive skeletal defects in revision surgery of total hip arthroplasty+ | |||||||||||||
Medical condition: Revision total hip arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005471-10 | Sponsor Protocol Number: 4745 | Start Date*: 2009-06-17 | |||||||||||
Sponsor Name:Nina Olofsson | |||||||||||||
Full Title: Plasma concentration of Ropivacain and Ketorolac after local infiltration during surgery in hip replacement during the first 24 postoperative hours. | |||||||||||||
Medical condition: Postoperative pain after surgery for hip replacement. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004906-12 | Sponsor Protocol Number: ASK-3-2011 | Start Date*: 2011-11-07 | |||||||||||
Sponsor Name:Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro | |||||||||||||
Full Title: Effect of hydroxyethyl starch on renal handling of sodium and water, vasoactive hormones,biomarkers and the circulatory system in patients undergoing hip replacement surgery | |||||||||||||
Medical condition: Patients undergoing hip replacement in spinal anesthesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001214-10 | Sponsor Protocol Number: AAUH-01-2015 | Start Date*: 2015-06-02 | ||||||||||||||||
Sponsor Name:Aalborg universitets hospital [...] | ||||||||||||||||||
Full Title: Analgetic effect of perioperative klorzoxazon at total hip or knee arthroplasty | ||||||||||||||||||
Medical condition: Perioperative pain after incertion of hip or knee arthroplasty | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-003695-31 | Sponsor Protocol Number: FIB | Start Date*: 2017-12-04 | |||||||||||
Sponsor Name:Ziekenhuis Oost-Limburg | |||||||||||||
Full Title: Fascia iliaca block for analgesia in unilateral direct anterior approach total hip arthroplasty | |||||||||||||
Medical condition: Total hip arthroplasty through minimal invasive muscle sparing surgery technique | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000107-94 | Sponsor Protocol Number: RB15.005 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:CHRU de Brest | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001708-14 | Sponsor Protocol Number: ABOGRAFT-01 | Start Date*: 2021-06-29 |
Sponsor Name:Region Östergötland | ||
Full Title: Antibiotic Impregnated Bone Graft to reduce infection in hip replacement. The ABOGRAFT trial | ||
Medical condition: Patients scheduled for any type of hip arthroplasty requiring bone grafting | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002122-12 | Sponsor Protocol Number: FICB2014 | Start Date*: 2014-07-17 | |||||||||||
Sponsor Name:az turnhout | |||||||||||||
Full Title: Longitudinal Fascia Iliaca Compartment Block for Total Hip Arthroplasty | |||||||||||||
Medical condition: Our hypothesis is that a longitudinal approach to the fascia iliaca with a larger volume of local anesthetic will decrease morphine consumption and pain scores in patients after total hip arthropla... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002636-25 | Sponsor Protocol Number: NBF_HK_03_2018 | Start Date*: 2018-10-23 | |||||||||||||||||||||
Sponsor Name:Anaesthesia Department, Hvidovre Hospital, Capital Region of Denmark. | |||||||||||||||||||||||
Full Title: Highdose Steroid for High Pain Responders undergoing Total Hip-arthroplasty - A randomized doubleblindet controlled trial. | |||||||||||||||||||||||
Medical condition: Perioperative management of total hip-arthroplasty because of hip-osteoarthritis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002889-12 | Sponsor Protocol Number: RH-4074-OJ2 | Start Date*: 2012-09-13 | ||||||||||||||||||||||||||
Sponsor Name:Pär I Johansson | ||||||||||||||||||||||||||||
Full Title: The effect of intraoperative low dose adrenaline on bleeding in total hip arthroplasty - a randomized placebo-controlled trial | ||||||||||||||||||||||||||||
Medical condition: intra- and postoperative blood loss in total hip arthroplasty | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-006528-67 | Sponsor Protocol Number: H-A-2008-030 | Start Date*: 2009-03-25 | |||||||||||
Sponsor Name:Hvidovre Hospital, Anæstesiologisk afdeling 532 | |||||||||||||
Full Title: Den perioperative effekt af methylprednisolon ved hoftealloplastik: et prospektivt, dobbeltblindet, placebokontrolleret studie. | |||||||||||||
Medical condition: Total hip arthroplasty, postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003730-10 | Sponsor Protocol Number: 001-2014-KHTY | Start Date*: 2014-12-01 | ||||||||||||||||
Sponsor Name:Department of Anesthesiology, Næstved Hospital | ||||||||||||||||||
Full Title: Effect of a lateral nerve of the thigh block on post-operative pain among patients with pain (VAS>40mm) during flexion of the hip the first or second postoperative day | ||||||||||||||||||
Medical condition: Pain after total hip replacement surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000692-14 | Sponsor Protocol Number: HKO-22112010 | Start Date*: 2011-11-03 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Hannu Kokki | ||||||||||||||||||||||||||||||||||||||
Full Title: | ||||||||||||||||||||||||||||||||||||||
Medical condition: | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000628-14 | Sponsor Protocol Number: ISS20109714 | Start Date*: 2013-09-13 | |||||||||||
Sponsor Name:Turku University Hospital | |||||||||||||
Full Title: Denosumab in enhancement of bone bonding of hip prosthesis in postmenopausal women: a randomized, double-blind, placebo-controlled study | |||||||||||||
Medical condition: Hip osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005599-33 | Sponsor Protocol Number: AMSC-BDT-001 | Start Date*: 2013-06-10 | |||||||||||
Sponsor Name:Lékařská fakulta Univerzity Karlovy v Hradci Králové | |||||||||||||
Full Title: Utilization of Autologous Multipotent Mesenchymal Stem Cells in the Management of the Large Skeletal Defects during Revision Total Hip Arthroplasty: a Prospective, Non-randomized, Open-Label Study ... | |||||||||||||
Medical condition: Revision total hip arthroplasty. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002965-19 | Sponsor Protocol Number: 1 | Start Date*: 2005-03-14 |
Sponsor Name:Orthopaedic department, Karolinska Institutet, Danderyd's Hospital | ||
Full Title: Can risedronate prevent periprosthetic bone loss after hip arthroplasty? A randomized, double-blind, placebo-controlled trial | ||
Medical condition: Periprosthetic bone loss after total hip arthroplasty (THA) is the main factor in limiting the longevity of implants used för treatment of osteoarthritis. Bone loss leads to implant destabilization... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024115-14 | Sponsor Protocol Number: 05-AnIt-09/UKM10_0027 | Start Date*: 2011-04-29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University Hospital Muenster | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Preoperative Intravenous Ferric Carboxymaltose (Ferinject) in Patients with Orthopaedic Surgery and High Risk of Blood Loss | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with iron deficiency anemia scheduled to undergo orthopedic surgery with high risk of bleeding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002457-41 | Sponsor Protocol Number: 150-CL-008 | Start Date*: 2006-05-15 | |||||||||||
Sponsor Name:Astellas Pharma Europe B.V. | |||||||||||||
Full Title: Direct Factor Xa inhibitor YM150 for prevention of venous thromboembolism in patients undergoing elective total hip replacement. A double blind, parallel, dose-finding study in comparison with open... | |||||||||||||
Medical condition: Elective primary hip replacement surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) CZ (Completed) SK (Completed) DE (Completed) SE (Completed) NO (Completed) FI (Completed) PT (Completed) GR (Completed) IT (Completed) LT (Completed) EE (Prematurely Ended) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003321-32 | Sponsor Protocol Number: 108 | Start Date*: 2021-01-21 | |||||||||||
Sponsor Name:Hvidovre Hospital, Dep. of Orthopaedic Surgery | |||||||||||||
Full Title: Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty | |||||||||||||
Medical condition: The benefit of additional Tranexamic Acid (TXA) injected intra-articular at the end of surgery for patients undergoing a unilateral total hip arthroplasty in addition to conventional IV TXA to redu... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001228-35 | Sponsor Protocol Number: Fybex01/ PAREXEL 71820 | Start Date*: 2005-11-23 |
Sponsor Name:Bio Products Laboratory | ||
Full Title: A randomized, single-blind, parallel-group, multi-center comparative study to assess the efficacy and safety of an application of Fybex (fibrin sealant) to the operative field, for the reduction of... | ||
Medical condition: Total hip arthroplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
